Stem cells in regenerative medicine

Pharmaceutical Journal

Volumn 275, Issue 7378, 2005, Pages 695-698

  Jell, Gavin ^b   Bonzani, Ian ^b   Stevens, Molly ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CLONING; EMBRYONIC STEM CELL; HEALTH CARE POLICY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; MEDICAL ETHICS; MESENCHYMAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PHARMACEUTICAL CARE; REGENERATIVE MEDICINE; SAFETY; STEM CELL; TISSUE ENGINEERING; UMBILICAL CORD BLOOD;

EID: 29244478603     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Hwang WS, Lee BC, Lee CK, Kang SK. Human embryonic stem cells and therapeutic cloning. Journal of Veterinary Science 2005;6:87-96.
2. Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiological Reviews 2005;85:635-78.
3. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GE, et al. Biology of haematopoietic stem cells and progenitors: implications for clinical application. Annual Review of Immunology 2003;21:759-806.
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
5. Holland S, Lebacqz K, Zoloth L (editors). The human embryonic stem cell debate: science, ethics, and public policy. Cambridge, US:The MIT Press; 2001.